| 000 | 01531 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250513035557.0 | ||
| 264 | 0 | _c19950316 | |
| 008 | 199503s 0 0 eng d | ||
| 022 | _a0923-7534 | ||
| 024 | 7 |
_a10.1093/oxfordjournals.annonc.a059020 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _avan der Gaast, A | |
| 245 | 0 | 0 |
_aPhase II study of carboplatin and etoposide as a first line regimen in patients with metastatic breast cancer. _h[electronic resource] |
| 260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _cNov 1994 |
||
| 300 |
_a858-60 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aCarboplatin _xadministration & dosage |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 |
_aEtoposide _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aBontenbal, M | |
| 700 | 1 | _aPlanting, A S | |
| 700 | 1 | _aKok, T C | |
| 700 | 1 | _aSplinter, T A | |
| 773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 5 _gno. 9 _gp. 858-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/oxfordjournals.annonc.a059020 _zAvailable from publisher's website |
| 999 |
_c7661358 _d7661358 |
||